Clinical trial

TGRX-326 Pharmacokinetic Food Effect Bioavailability Study

NCT06304805

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-12-13

PhasePHASE1

Study timeline

Study start (actual)2023-12-13Date precision: day

Registry last updated2025-05-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non Small Cell Lung Cancerunresolved

Interventions

cycle 1: treatment drugDRUG

cycle 1: reference drugDRUG

cycle 1: fastedBEHAVIORAL

cycle 1: foodBEHAVIORAL

cycle 2: treatment drugDRUG

cycle 2: reference drugDRUG

cycle 2: fastedBEHAVIORAL

cycle 2: foodBEHAVIORAL

cycle 3: treatment drugDRUG

cycle 3: reference drugDRUG

cycle 3: fastedBEHAVIORAL

cycle 3: foodBEHAVIORAL

Sponsors & collaborators

Shenzhen TargetRx Co., Ltd.lead sponsor

The First Affiliated Hospital of Bengbu Medical Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06304805 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.